We therefore also compared a cohort of BRCA2-/- tumors to a cohort of BRCA2+/+ genome-instable head and neck squamous cell carcinoma ((HNSCC) cohort46; Supplementary Data 7; see Methods). The gene discussed is BRCA2; the disease is head and neck squamous cell carcinoma.